What changed
$CRWD — AVOID 📊 | 6 MONTHS THESIS
🧭 Conviction: HIGH
🎯 FQ1 FY2027 (ends Apr) | reported Jun 03 | Rev $1.4B | EPS $1.10 vs $1.07 🟢 | Margin -2.2%
💡 The market expects sustained hyper-growth and imminent margin expansion to justify the current $701 price, but the modest 2.8% EPS beat and -2.2% operating margin show that profitability remains elusive and growth is not accelerating enough to support the extreme multiple.
🏢 Business Quality: 6/10
📊 Valuation: rich — trailing P/E 159.3x vs peer range 7.4x–46.2x; FCF yield 0.28%; DCF implies -4.6% FCF growth embedded; EV/EBITDA not meaningful due to negative...
🔮 Catalyst: next quarterly earnings release
⚖️ Avoid — CRWD's 159x P/E far exceeds any rational fundamental value (bull case $288), offering 0.1:1 reward/risk; the modest EPS beat does not justify the extreme multiple, and historical analogs suggest significant downside.